Literature DB >> 6332369

Osteopenia with normal vitamin D metabolites after small-bowel resection for Crohn's disease.

I Hessov, L Mosekilde, F Melsen, S Fasth, L Hultén, B Lund, B Lund, O H Sørensen.   

Abstract

Thirty-six unselected patients were investigated 3-24 years (mean, 7.8 years) after small-bowel resection for Crohn's disease (mean small intestinal resection, 105 cm). Iliac crest bone biopsies after in vivo tetracycline double-labelling showed a markedly reduced trabecular bone mass (controls, 0.25 +/- 0.06; patients, 0.15 +/- 0.05; p less than 0.01). The average bone remodeling and osteoid mineralization was normal, and only two patients demonstrated signs of frank but slight osteomalacia. The mean serum levels of the three vitamin D metabolites 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D, and 1,25-dihydroxyvitamin D were normal. The observed reduction in trabecular bone mass may theoretically be followed by an increased risk of spontaneous fractures.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6332369

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  14 in total

1.  Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density.

Authors:  M T Abreu; V Kantorovich; E A Vasiliauskas; U Gruntmanis; R Matuk; K Daigle; S Chen; D Zehnder; Y-C Lin; H Yang; M Hewison; J S Adams
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

2.  Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease?

Authors:  E J Schoon; M C Müller; C Vermeer; L J Schurgers; R J Brummer; R W Stockbrügger
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

Review 3.  Laboratory assessment of inflammatory bowel disease.

Authors:  I T Beck
Journal:  Dig Dis Sci       Date:  1987-12       Impact factor: 3.199

4.  Vitamin D status in children and young adults with inflammatory bowel disease.

Authors:  Helen M Pappa; Catherine M Gordon; Tracee M Saslowsky; Anna Zholudev; Brian Horr; Mei-Chiung Shih; Richard J Grand
Journal:  Pediatrics       Date:  2006-11       Impact factor: 7.124

5.  Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease.

Authors:  P I Croucher; S Vedi; R J Motley; N J Garrahan; M R Stanton; J E Compston
Journal:  Osteoporos Int       Date:  1993-09       Impact factor: 4.507

6.  Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodelling, vitamin D metabolites, and bone histomorphometry.

Authors:  S Bisballe; E F Eriksen; F Melsen; L Mosekilde; O H Sørensen; I Hessov
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

7.  Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection.

Authors:  K V Haderslev; P B Jeppesen; H A Sorensen; P B Mortensen; M Staun
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

8.  Iliac bone histomorphometry in children with newly diagnosed inflammatory bowel disease.

Authors:  L M Ward; F Rauch; M A Matzinger; E I Benchimol; M Boland; D R Mack
Journal:  Osteoporos Int       Date:  2009-06-06       Impact factor: 4.507

9.  Bone loss in patients with inflammatory bowel disease: a prospective study.

Authors:  C Roux; V Abitbol; S Chaussade; S Kolta; S Guillemant; M Dougados; B Amor; D Couturier
Journal:  Osteoporos Int       Date:  1995-05       Impact factor: 4.507

10.  Bone disease in vitamin D-deficient patients with Crohn's disease.

Authors:  H Vogelsang; P Ferenci; W Woloszczuk; H Resch; C Herold; S Frotz; A Gangl
Journal:  Dig Dis Sci       Date:  1989-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.